Palo Alto-based InteKrin Therapeutics, a stealth startup working on treatments for neuroendocrine and metabolic diseases, has received a round of funding, according to a regulatory filing. Investors in InteKrin include Sears Capital Management, which is headed by former Amgen CFO Lowell Sears. More information »